In recent years, great strides have been made in our understanding of cardiovascular pharmacology. However, the rapid pace of new drugs being introduced, such as those for ischemic heart disease, arrhythmias, and myocardial failure, healthcare professionals have found it difficult to stay abreast, let alone incorporate these new drugs into their clinical practice.
Current Cardiovascular Drugs, 3rd Ed. provides, in one concise source, the latest knowledge of cardiovascular drug therapy, covering all of the cardivascular drug classes. Also addressed are pharmacological characteristics of specific agents, the clinical efficacy and limitations of various drug therapies, and innovative approaches to pharmacotherapy. Plus, you can look ahead with the Drugs in Development chapter, which highlights the clinical investigations of the future. For futher research, suggested readings are listed at the end of every chapter. Easy-to-use appendices are provided which break down of drug use recommendations and list cardiovascular drug trial acronyms.